Humacyte, Inc. (HUMA) Tops Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts HUMA Hot Sheet
Join SI Premium – FREE
Humacyte, Inc. (NASDAQ: HUMA) reported Q3 EPS of ($0.11), $0.05 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $753 thousand versus the consensus estimate of $917.95 thousand.
For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Humacyte adds two nephrologists as advisors for dialysis product push
- JBT Automated Systems rebrands as Formova
- Citigroup (C) Tops Q2 EPS by 42c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
